Birdwatch Note Rating
2023-03-15 21:39:08 UTC - NOT_HELPFUL
Rated by Participant: 5F3FEEEA4B65ED345DAE872C369EBD16D567DEAC24EF4BC2780EA275F1673238
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details